Nebulised liposomal amphotericin B for Aspergillus lung diseases: case series and literature review

E-ISSN： 1439-0507|58|3|173-180

ISSN： 0933-7407

Source： MYCOSES (ELECTRONIC), Vol.58, Iss.3, 2015-03, pp. : 173-180

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Five-year survival after palliative radiotherapy of T4/N3 lung cancer: case series and review of the literature

Journal of Radiotherapy in Practice, Vol. 14, Iss. 1, 2014-08 ,pp. : 102-104

Cambridge University Press

Access to resources Recommend Favorite

Experience with leflunomide as treatment and as secondary prophylaxis for cytomegalovirus infection in lung transplant recipients: A case series and review of the literature

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 32, Iss. 2, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evaluation of the safety and efficacy of liposomal amphotericin B (L-AMB) in children

By Sunakawa Keisuke

Journal of Infection and Chemotherapy, Vol. 18, Iss. 4, 2012-08 ,pp. : 456-465

Springer Publishing Company

Access to resources Recommend Favorite

Prophylactic Application of Nebulized Liposomal Amphotericin B in Hematologic Patients with Neutropenia

Oncology Research and Treatment, Vol. 34, Iss. 5, 2011-04 ,pp. : 254-258

Karger

Access to resources Recommend Favorite

Cost-Benefit Assessment of Antifungal Prophylaxis with Liposomal Amphotericin B in Neutropenic Patients

Oncology Research and Treatment, Vol. 30, Iss. 12, 2007-11 ,pp. : 621-626

Karger

Access to resources Recommend Favorite